Assignee
GALLAGHER GRANT
US·14 granted patents·2 pending applications·78 citations·filing 2008–2016
Top patents by PatentIndex Score
16 records- 0195US8946150B2Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereofGALLAGHER GRANT·Filed 2012·Granted Feb 3, 2015·34 cites·17 claims
- 0294US9169292B2Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereofGALLAGHER GRANT·Filed 2013·Granted Oct 27, 2015·34 cites·5 claims
- 0386US9605027B2Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereofGALLAGHER GRANT·Filed 2015·Granted Mar 28, 2017·6 cites·13 claims
- 0475US8282964B2Ex-vivo treatment of peripheral plasmacytoid dendritic cells with IFN-lambdaGALLAGHER GRANT·Filed 2009·Granted Oct 9, 2012·3 cites·18 claims
- 0574US9868776B2Anti-sense oligonucleotides targeted against exon 9 of IL-23R-alpha gene and method of using same to induce exon skipping and to treat inflammatory bowel diseasesGALLAGHER GRANT·Filed 2015·Granted Jan 16, 2018·1 cites·9 claims
- 0669US8206925B2Splice variants of human IL-23 receptor (IL-23R) mRNA and use of a delta 9 isoform in predicting inflammatory bowel diseasesGALLAGHER GRANT·Filed 2009·Granted Jun 26, 2012·0 cites·5 claims
- 0765US9464321B2Methods and reagents that specifically detect, distinguish and quantify IFN-λ2 mRNA from IFN-λ3 mRNA in humansGALLAGHER GRANT·Filed 2014·Granted Oct 11, 2016·0 cites·12 claims
- 0864US9187750B2Anti-sense oligonucleotides targeted against exon 9 of IL-23Rα gene and method of using same to induce exon skipping and to treat inflammatory bowel diseasesGALLAGHER GRANT·Filed 2013·Granted Nov 17, 2015·0 cites·12 claims
- 0962US10416172B2Recombinant soluble truncated IL-23 receptor (IL-23R) capable of inhibiting IL-23R-mediated cell signalingGALLAGHER GRANT·Filed 2011·Granted Sep 17, 2019·0 cites·14 claims
- 1059US10144974B2Methods and reagents that specifically detect, distinguish and quantify IFN-LAMBDA2 mRNA from IFN-LAMBDA3 mRNA in humansGALLAGHER GRANT·Filed 2016·Granted Dec 4, 2018·0 cites·3 claims
- 1159US2013196333A1SPLICE VARIANTS OF HUMAN IL-23 RECEPTOR (IL-23R) mRNA AND USE OF A DELTA 9 ISOFORM IN PREDICTING INFLAMMATORY BOWEL DISEASESGALLAGHER GRANT·Filed 2013·Application pending·0 cites
- 1258US2013183755A1Therapeutic application of isolated naturally-occurring soluble truncated forms of il-23 receptorGALLAGHER GRANT·Filed 2013·Application pending·0 cites
- 1357US8618070B2Anti-sense oligonucleotides targeted against exon 9 of IL-23Rα gene and method of using same to induce exon skipping and to treat inflammatory bowel diseasesGALLAGHER GRANT·Filed 2011·Granted Dec 31, 2013·0 cites·4 claims
- 1455US9523073B2Elisa for a naturally-occurring soluble truncated form of IL-23 receptorGALLAGHER GRANT·Filed 2011·Granted Dec 20, 2016·0 cites·12 claims
- 1555US8354125B2Ex-vivo treatment of peripheral blood leukocytes with IFN-λGALLAGHER GRANT·Filed 2008·Granted Jan 15, 2013·0 cites·14 claims
- 1646US8771666B2Ex-vivo treatment of T-cells with IFN-λGALLAGHER GRANT·Filed 2012·Granted Jul 8, 2014·0 cites·15 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →